{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T02:45:09Z","timestamp":1786243509386,"version":"build-2736575974"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T00:00:00Z","timestamp":1308614400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021217","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T16:56:39Z","timestamp":1308675399000},"page":"e21217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections"],"prefix":"10.1371","volume":"6","author":[{"given":"Sebastiaan J.","family":"van Hal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B.","family":"Gosbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1086\/598186","article-title":"Staphylococcus aureus bloodstream infections: definitions and treatment.","volume":"48","author":"GR Corey","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5694\/j.1326-5377.2009.tb02841.x","article-title":"Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand.","volume":"191","author":"JD Turnidge","year":"2009","journal-title":"Med J Aust"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QCO.0b013e328331fbcd","article-title":"Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.","volume":"22","author":"K Chua","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.","volume":"40","author":"K Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.","volume":"350","author":"K Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.","volume":"200","author":"IG Bae","year":"2009","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates.","volume":"55","author":"SJ van Hal","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.00582-08","article-title":"Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).","volume":"46","author":"MJ Rybak","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.","volume":"38","author":"PG Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.","volume":"199","author":"Y Maor","year":"2009","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-6-13","article-title":"Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections.","volume":"6","author":"HM Neoh","year":"2007","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.","volume":"47","author":"AC Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"A Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref14","article-title":"Clinical characteristics of vancomycin minimum inhibitory concentration of 2 mug\/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.","author":"Y Takesue","year":"2010","journal-title":"J Infect Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-8-39","article-title":"Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"8","author":"BP Howden","year":"2008","journal-title":"BMC Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.00073-06","article-title":"In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.","volume":"50","author":"N McCallum","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/596511","article-title":"Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.","volume":"199","author":"AY Peleg","year":"2009","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.01365-08","article-title":"Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.","volume":"53","author":"KC Horne","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","article-title":"The presence of vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus blood stream infections is not associated with increased mortality.","author":"SJ van Hal","year":"2010"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: We Can't Get There from Here.","volume":"52","author":"N Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.","volume":"23","author":"BP Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JCM.02302-10","article-title":"Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates.","volume":"49","author":"SJ van Hal","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1001\/jama.290.24.3207","article-title":"Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis.","volume":"290","author":"HR Vikram","year":"2003","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.","volume":"49","author":"G Sakoulas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/AAC.46.5.1492-1502.2002","article-title":"Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.","volume":"46","author":"G Sakoulas","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.","volume":"166","author":"LK Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref27","article-title":"Increased mortality in patients with Staphylococcus aureus bacteraemia (SAB) with elevated vancomycin MIC regardless of antibiotic treatment.","author":"N Holmes","year":"2010"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"51","author":"PA Moise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"42","author":"G Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.","volume":"42","author":"RN Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref31","article-title":"Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S20","year":"2010"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.","volume":"39","author":"TR Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jac\/47.3.357","article-title":"Detection of glycopeptide resistance in Staphylococcus aureus.","volume":"47","author":"TR Walsh","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/502156","article-title":"Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.","volume":"24","author":"O Lesens","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"TC Horan","year":"2008","journal-title":"Am J Infect Control"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T09:46:07Z","timestamp":1592646367000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021217"}},"subtitle":[],"editor":[{"given":"Lorenzo","family":"Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,21]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021217","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13485017.14862142","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,21]]}}}